Vasant Narasimhan, Biotech
Novartis Plans $12B Acquisition to Expand Neuroscience RNA Therapies
50% center coverage2 sources
Vasant Narasimhan
United States Politics
Discover the latest news, candidates, and key topics of US politics
Latest News
Vasant Narasimhan, Biotech
Novartis Plans $12B Acquisition to Expand Neuroscience RNA Therapies
50% center coverage2 sources
Vasant Narasimhan
Novartis Plans $12B Acquisition of Avidity to Boost Rare Muscle Disease Pipeline
100% left coverage1 source
Vasant Narasimhan
Novartis Plans $12B Acquisition of Avidity to Boost Rare Muscle Disease Pipeline
100% left coverage1 source
Vasant Narasimhan, Business Leaders
Novartis Boosts U.S. Drug Stockpiles Ahead Potential Tariffs
50% center coverage2 sources
Vasant Narasimhan, Business Leaders
Novartis Boosts U.S. Drug Stockpiles Ahead Potential Tariffs
50% center coverage2 sources
Vasant Narasimhan, Business Leaders
Novartis Plans US Drug Price Cuts Amid Government Pressure
50% center coverage4 sources
Vasant Narasimhan, Business Leaders
Novartis Plans US Drug Price Cuts Amid Government Pressure
50% center coverage4 sources
Vasant Narasimhan
US Drug Price Strategy Sparks Concerns Over European Medicine Access
100% center coverage1 source
Vasant Narasimhan
US Drug Price Strategy Sparks Concerns Over European Medicine Access
100% center coverage1 source
Vasant Narasimhan
Drug prices with Medicare
100% center coverage1 source
Vasant Narasimhan
Drug prices with Medicare
100% center coverage1 source
Vasant Narasimhan, Drugs
Medicare drug prices
67% left coverage3 sources
Vasant Narasimhan, Drugs
Medicare drug prices
67% left coverage3 sources
United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Vasant Narasimhan
News from Vasant Narasimhan